IL-17 firmly amplified TNF-α, CCL20, and IL-23 mRNA and increased the activation of NF-κB, p38, and Erk pathways in intestinal neuroendocrine and goblet cells in human IBD [49]. Here, IL17A is linked to inflammatory bowel disease.